NCT00178620View on ClinicalTrials.gov

Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization

PHASE4CompletedINTERVENTIONAL
Enrollment

390

Participants

Timeline

Start Date

September 30, 2003

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Heart DiseaseMyocardial InfarctionAcute Myocardial Infarction
Interventions
DRUG

Reteplase 10 Units (U) plus a second dose of reteplase 10 U

Thrombolytic-clot busting drug Retavase IV Bolus, 10 U followed by a second 10U dose

DRUG

Reteplase 10 U

Thrombolytic-clot busting drug Retavase IV Bolus in one 10U dose

PROCEDURE

Urgent Percutaneous Coronary Intervention (PCI)

PROCEDURE

Primary Percutaneous Coronary Intervention (PCI)

Trial Locations (1)

77030

Memorial Hermann Hospital / The University of Texas HSC, Houston

All Listed Sponsors
lead

The University of Texas Health Science Center, Houston

OTHER

NCT00178620 - Pre-hospital Administration of Thrombolytic Therapy With Urgent Culprit Artery Revascularization | Biotech Hunter | Biotech Hunter